Antarka Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 7

Antarka General Information

Description

Developer of a biotechnology platform designed to repair UV-induced DNA damage in skin cells for skin longevity. The company's platform offers skin-permeable DNA-repair enzymes derived from Antarctic extremophile microorganisms with scalable purity for topical use, enabling cosmetic and skincare formulators to integrate ingredients that address photoaging with validated safety and efficacy.

Contact Information

Website
www.antarka.bio
Formerly Known As
DNAzyme
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenida Italia 6201, Parque Tecnológico del LATU Edificio Los Tilos
  • Office 106
  • Montevideo, Montevideo 11500
  • Uruguay
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Avenida Italia 6201, Parque Tecnológico del LATU Edificio Los Tilos
  • Office 106
  • Montevideo, Montevideo 11500
  • Uruguay

Antarka Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antarka Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round Upcoming Startup
3. Seed Round 31-Dec-2025 Completed Startup
2. Accelerator/Incubator 10-Sep-2024 $400K $600K Completed Startup
1. Accelerator/Incubator 01-Aug-2023 $200K $200K Completed Startup
To view Antarka’s complete valuation and funding history, request access »

Antarka Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Antarka Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229912-A1 Skin care compositions and methods Pending 30-Apr-2025

Antarka Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Antarka Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIR Capital Venture Capital Minority
GS Futures Corporate Venture Capital Minority
Vox Capital Venture Capital Minority
Zentynel Frontier Investments Venture Capital Minority
IndieBio Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Antarka FAQs

  • When was Antarka founded?

    Antarka was founded in 2023.

  • Where is Antarka headquartered?

    Antarka is headquartered in Montevideo, Uruguay.

  • What is the size of Antarka?

    Antarka has 7 total employees.

  • What industry is Antarka in?

    Antarka’s primary industry is Biotechnology.

  • Is Antarka a private or public company?

    Antarka is a Private company.

  • What is Antarka’s current revenue?

    The current revenue for Antarka is .

  • How much funding has Antarka raised over time?

    Antarka has raised $4.1M.

  • Who are Antarka’s investors?

    AIR Capital, GS Futures, Vox Capital, Zentynel Frontier Investments, and IndieBio are 5 of 7 investors who have invested in Antarka.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process